Source: LHGDN

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 GeneticVariation LHGDN MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. 18093943

2007
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis. 17459054

2007
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN [Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma]. 18172343

2007
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma. 17132227

2006
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma. 16426920

2006
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. 16186806

2006
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN Met receptor signaling: a key effector in esophageal adenocarcinoma. 17062664

2006
Entrez Id: 4233
Gene Symbol: MET
MET
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma 		0.400 AlteredExpression LHGDN The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. 15720819

2005